Partner Kathleen Sanzo, a leader in our life sciences practice, spoke to The Pink Sheet about new dietary ingredients (NDI) notifications. "All of the concern and uncertainty in the industry really results from the FDA not providing a guidance," Kathy says in the article, pointing to the FDA’s tight resources as the reason new NDI notification hasn’t been provided.